| Medicamen Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531146 |
NSE Symbol : MEDICAMEQ |
P/E(TTM) : 43.51 |
|
ISIN Demat : INE646B01010 |
Div & Yield% : 0.30 |
EPS(TTM) : 7.59 |
|
Book Value(₹) : 199.90 |
Market Cap(₹Cr) : 447.91 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 43.85 | 54.68 | 43.49 | 42.23 | 38.45 | 26.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 43.85 | 54.68 | 43.49 | 42.23 | 38.45 | 26.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.86 | 1.73 | 0.53 | 0.37 | 0.47 | 5.22 |
| Total Income | 44.71 | 56.41 | 44.03 | 42.60 | 38.92 | 31.21 |
| Total Expenditure | 39.07 | 50.55 | 38.41 | 37.18 | 34.41 | 27.09 |
| PBIDT | 5.64 | 5.85 | 5.61 | 5.42 | 4.50 | 4.13 |
| Interest | 0.64 | 0.60 | 0.78 | 0.84 | 0.56 | 0.62 |
| PBDT | 5.00 | 5.25 | 4.83 | 4.58 | 3.94 | 3.50 |
| Depreciation | 1.74 | 1.73 | 1.75 | 1.81 | 1.77 | 0.47 |
| Tax | 0.83 | 0.65 | 0.64 | 0.68 | 0.57 | 0.73 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.10 | -0.10 | -0.16 | -0.12 | -0.04 | -0.10 |
| Reported Profit After Tax | 2.53 | 2.97 | 2.59 | 2.21 | 1.64 | 2.41 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.53 | 2.97 | 2.59 | 2.21 | 1.64 | 2.41 |
| EPS (Unit Curr.) | 1.86 | 2.19 | 1.91 | 1.63 | 1.21 | 1.90 |
| EPS (Adj) (Unit Curr.) | 1.86 | 2.19 | 1.91 | 1.63 | 1.21 | 1.90 |
| Calculated EPS (Unit Curr.) | 1.86 | 2.19 | 1.91 | 1.63 | 1.21 | 1.90 |
| Calculated EPS (Adj) (Unit Curr.) | 1.86 | 2.19 | 1.91 | 1.63 | 1.21 | 1.90 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.45 | 8.77 | 7.65 | 6.50 | 4.83 | 7.58 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.45 | 8.77 | 7.65 | 6.50 | 4.83 | 7.58 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.56 | 13.56 | 13.56 | 13.56 | 13.56 | 12.71 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 12.86 | 10.70 | 12.90 | 12.83 | 11.70 | 15.88 |
| PBDTM(%) | 11.40 | 9.60 | 11.11 | 10.85 | 10.25 | 13.46 |
| PATM(%) | 5.77 | 5.43 | 5.96 | 5.23 | 4.27 | 9.27 |
